Is It Too Late To Consider ImmunityBio (IBRX) After Its Recent Share Price Surge
- If you are wondering whether ImmunityBio’s recent share price action still leaves room for value, this article walks through what the current price might be implying about the business.
- The stock last closed at US$9.54, with returns of 11.7% over 7 days, 53.6% over 30 days, 372.3% year to date and 218.0% over 1 year, which will naturally raise questions about growth expectations and changing risk perceptions.
- Recent news around ImmunityBio has focused on its position in the pharmaceuticals and biotech space and investor interest in its pipeline and partnerships, which helps explain why the share price has attracted attention. These developments give useful context when you are thinking about whether the current valuation is driven more…
Source link
